Zosano Pharma Corp — Operating Income by Fiscal Year
8 fiscal years, as filed with the SEC; every row links its evidence fact.
Cite as: FACTANKER, https://factanker.com/entity/21a369e1-de8a-4dab-b51c-eea847450d41/serie/operating-income
| Fiscal year | Operating Income | Period | Evidence |
|---|---|---|---|
| FY 2021 | $-31.5M | 2021-01-01 – 2021-12-31 | evidence 0001587221-22-000022 |
| FY 2020 | $-32.8M | 2020-01-01 – 2020-12-31 | evidence 0001587221-21-000007 |
| FY 2019 | $-37.2M | 2019-01-01 – 2019-12-31 | evidence 0001587221-20-000004 |
| FY 2018 | $-35.4M | 2018-01-01 – 2018-12-31 | evidence 0001587221-19-000006 |
| FY 2017 | $-28.4M | 2017-01-01 – 2017-12-31 | evidence 0001193125-18-078418 |
| FY 2016 | $-28.6M | 2016-01-01 – 2016-12-31 | evidence 0001193125-17-063319 |
| FY 2015 | $-26.4M | 2015-01-01 – 2015-12-31 | evidence 0001193125-16-521425 |
| FY 2014 | $-12.6M | 2014-01-01 – 2014-12-31 | evidence 0001193125-16-521425 |
Methodology & sources
One value per fiscal year (period > 300 days, latest period end per year); fiscal years ending Jun–Dec count toward the ending calendar year, Jan–May toward the prior year. Values as filed (XBRL concept per evidence fact). Source: SEC EDGAR (public domain).
One value per fiscal year (period > 300 days, latest period end per year); fiscal years ending Jun–Dec count toward the ending calendar year, Jan–May toward the prior year. Values as filed (XBRL concept per evidence fact). Source: SEC EDGAR (public domain).